Skip to main content

Peer Review reports

From: Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway

Original Submission
6 Sep 2021 Submitted Original manuscript
11 Dec 2021 Reviewed Reviewer Report - Rosa Marina Melillo
24 Dec 2021 Reviewed Reviewer Report - Keisuke Enomoto
21 Jan 2022 Author responded Author comments - Yanping Gong
15 Feb 2022 Author responded Author comments - Yanping Gong
Resubmission - Version 2
21 Jan 2022 Submitted Manuscript version 2
12 Mar 2022 Author responded Author comments - Yanping Gong
Resubmission - Version 3
12 Mar 2022 Submitted Manuscript version 3
16 Mar 2022 Author responded Author comments - Yanping Gong
Resubmission - Version 4
16 Mar 2022 Submitted Manuscript version 4
30 Mar 2022 Reviewed Reviewer Report - Rosa Marina Melillo
5 Apr 2022 Reviewed Reviewer Report - Keisuke Enomoto
12 Apr 2022 Author responded Author comments - Yanping Gong
Resubmission - Version 5
12 Apr 2022 Submitted Manuscript version 5
22 Apr 2022 Reviewed Reviewer Report - Keisuke Enomoto
5 May 2022 Reviewed Reviewer Report - Rosa Marina Melillo
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
5 May 2022 Editorially accepted
31 May 2022 Article published 10.1186/s12885-022-09643-9

You can find further information about peer review here.

Back to article page